SEC
|
Detheux Michel
|
Chief Executive Officer
|
|
-105K
|
$10.02
|
-$1.05M
|
|
SEC
|
Detheux Michel
|
Chief Executive Officer
|
|
-157K
|
$10.15
|
-$1.59M
|
|
SEC
|
Hallal David
|
N/A
|
|
-115K
|
$10.15
|
-$1.16M
|
|
SEC
|
EcoR1 Capital, LLC
|
N/A
|
|
+5M
|
$7.80
|
+$38.68M
|
|
SEC
|
Foley Todd
|
N/A
|
|
-630K
|
$8.06
|
-$5.08M
|
|
SEC
|
UBS Oncology Impact Fund L.P.
|
N/A
|
|
-1M
|
$8.06
|
-$8.32M
|
|
SEC
|
Gall Matthew
|
Chief Financial Officer
|
|
+5K
|
$7.73
|
+$38.65K
|
|
SEC
|
Gall Matthew
|
Chief Financial Officer
|
|
+5K
|
$8.37
|
+$41.85K
|
|
SEC
|
Davis Aaron I.
|
N/A
|
|
-350K
|
$16.26
|
-$5.69M
|
|
SEC
|
Davis Aaron I.
|
N/A
|
|
-663K
|
$21.04
|
-$13.95M
|
|
SEC
|
Davis Aaron I.
|
N/A
|
|
-375K
|
$27.33
|
-$10.25M
|
|
SEC
|
Davis Aaron I.
|
N/A
|
|
+50K
|
$32.51
|
+$1.63M
|
|
SEC
|
Detheux Michel
|
Chief Executive Officer
|
|
-18K
|
$34.17
|
-$629.99K
|
|
SEC
|
LEWIS JOSEPH
|
N/A
|
|
-575K
|
$35.25
|
-$20.28M
|
|
SEC
|
Detheux Michel
|
Chief Executive Officer
|
|
-15K
|
$34.34
|
-$497.93K
|
|
SEC
|
Detheux Michel
|
Chief Executive Officer
|
|
-15K
|
$35.68
|
-$517.36K
|
|
SEC
|
Lager Joanne Jenkins
|
Chief Medical Officer
|
|
-3.5K
|
$39.32
|
-$137.62K
|
|
SEC
|
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
|
N/A
|
|
-147K
|
$42.58
|
-$6.25M
|
|
SEC
|
MPM BioVentures 2018 GP LLC
|
N/A
|
|
-147K
|
$42.58
|
-$6.25M
|
|
SEC
|
Oncology Impact Fund (Cayman) Management L.P.
|
N/A
|
|
-245K
|
$42.58
|
-$10.45M
|
|
SEC
|
Davis Aaron I.
|
N/A
|
|
-700K
|
$46.54
|
-$32.58M
|
|
SEC
|
Gall Matthew
|
Chief Financial Officer
|
|
-5K
|
$46.45
|
-$232.25K
|
|
SEC
|
Detheux Michel
|
Chief Executive Officer
|
|
-15K
|
$28.34
|
-$410.93K
|
|
SEC
|
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
|
N/A
|
|
-50K
|
$33.73
|
-$1.68M
|
|
SEC
|
MPM BioVentures 2018 GP LLC
|
N/A
|
|
-50K
|
$33.73
|
-$1.68M
|
|
SEC
|
Oncology Impact Fund (Cayman) Management L.P.
|
N/A
|
|
-83K
|
$33.73
|
-$2.81M
|
|
SEC
|
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
|
N/A
|
|
-84K
|
$34.47
|
-$2.88M
|
|
SEC
|
MPM BioVentures 2018 GP LLC
|
N/A
|
|
-84K
|
$34.47
|
-$2.88M
|
|
SEC
|
Oncology Impact Fund (Cayman) Management L.P.
|
N/A
|
|
-140K
|
$34.47
|
-$4.82M
|
|
SEC
|
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
|
N/A
|
|
-23K
|
$35.18
|
-$810.72K
|
|
SEC
|
MPM BioVentures 2018 GP LLC
|
N/A
|
|
-23K
|
$35.18
|
-$810.72K
|
|
SEC
|
Oncology Impact Fund (Cayman) Management L.P.
|
N/A
|
|
-39K
|
$35.18
|
-$1.36M
|
|
SEC
|
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
|
N/A
|
|
-93K
|
$30.45
|
-$2.84M
|
|
SEC
|
MPM BioVentures 2018 GP LLC
|
N/A
|
|
-93K
|
$30.45
|
-$2.84M
|
|
SEC
|
Oncology Impact Fund (Cayman) Management L.P.
|
N/A
|
|
-145K
|
$32.66
|
-$4.75M
|
|
SEC
|
Detheux Michel
|
Chief Executive Officer
|
|
+1.8K
|
$23.59
|
+$41.59K
|
|
SEC
|
Detheux Michel
|
Chief Executive Officer
|
|
-21K
|
$28.55
|
-$586.90K
|
|
SEC
|
Detheux Michel
|
Chief Executive Officer
|
|
-196
|
$28.00
|
-$5.49K
|
|
SEC
|
Detheux Michel
|
Chief Executive Officer
|
|
-1.8K
|
$28.01
|
-$51.43K
|
|
SEC
|
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
|
N/A
|
|
-17K
|
$27.45
|
-$469.37K
|
|
SEC
|
MPM BioVentures 2018 GP LLC
|
N/A
|
|
-17K
|
$27.45
|
-$469.37K
|
|
SEC
|
Oncology Impact Fund (Cayman) Management L.P.
|
N/A
|
|
-29K
|
$27.45
|
-$785.48K
|
|
SEC
|
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
|
N/A
|
|
-57K
|
$27.21
|
-$1.54M
|
|
SEC
|
MPM BioVentures 2018 GP LLC
|
N/A
|
|
-57K
|
$27.21
|
-$1.54M
|
|
SEC
|
Oncology Impact Fund (Cayman) Management L.P.
|
N/A
|
|
-95K
|
$27.21
|
-$2.59M
|
|
SEC
|
Gall Matthew
|
Chief Financial Officer
|
|
+14K
|
$6.16
|
+$88.88K
|
|
SEC
|
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
|
N/A
|
|
-52K
|
$27.23
|
-$1.42M
|
|
SEC
|
MPM BioVentures 2018 GP LLC
|
N/A
|
|
-52K
|
$27.23
|
-$1.42M
|
|
SEC
|
Oncology Impact Fund (Cayman) Management L.P.
|
N/A
|
|
-87K
|
$27.23
|
-$2.37M
|
|
SEC
|
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
|
N/A
|
|
-28K
|
$27.05
|
-$745.66K
|
|
SEC
|
MPM BioVentures 2018 GP LLC
|
N/A
|
|
-28K
|
$27.05
|
-$745.66K
|
|
SEC
|
Oncology Impact Fund (Cayman) Management L.P.
|
N/A
|
|
-46K
|
$27.05
|
-$1.25M
|
|
SEC
|
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
|
N/A
|
|
-22K
|
$27.00
|
-$580.66K
|
|
SEC
|
MPM BioVentures 2018 GP LLC
|
N/A
|
|
-22K
|
$27.00
|
-$580.66K
|
|
SEC
|
Oncology Impact Fund (Cayman) Management L.P.
|
N/A
|
|
-36K
|
$27.00
|
-$971.73K
|
|
SEC
|
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
|
N/A
|
|
-53K
|
$27.76
|
-$1.48M
|
|
SEC
|
MPM BioVentures 2018 GP LLC
|
N/A
|
|
-53K
|
$27.76
|
-$1.48M
|
|
SEC
|
Oncology Impact Fund (Cayman) Management L.P.
|
N/A
|
|
-89K
|
$27.76
|
-$2.48M
|
|
SEC
|
Detheux Michel
|
Chief Executive Officer
|
|
-6.4K
|
$28.14
|
-$180.41K
|
|
SEC
|
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
|
N/A
|
|
-34K
|
$27.50
|
-$933.05K
|
|
SEC
|
MPM BioVentures 2018 GP LLC
|
N/A
|
|
-34K
|
$27.50
|
-$933.05K
|
|
SEC
|
Oncology Impact Fund (Cayman) Management L.P.
|
N/A
|
|
-57K
|
$27.50
|
-$1.56M
|
|
SEC
|
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
|
N/A
|
|
-91K
|
$28.38
|
-$2.59M
|
|
SEC
|
MPM BioVentures 2018 GP LLC
|
N/A
|
|
-91K
|
$28.38
|
-$2.59M
|
|
SEC
|
Oncology Impact Fund (Cayman) Management L.P.
|
N/A
|
|
-153K
|
$28.38
|
-$4.33M
|
|
SEC
|
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
|
N/A
|
|
-46K
|
$27.70
|
-$1.26M
|
|
SEC
|
MPM BioVentures 2018 GP LLC
|
N/A
|
|
-46K
|
$27.70
|
-$1.26M
|
|
SEC
|
Oncology Impact Fund (Cayman) Management L.P.
|
N/A
|
|
-76K
|
$27.70
|
-$2.12M
|
|
SEC
|
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
|
N/A
|
|
-58K
|
$28.32
|
-$1.63M
|
|
SEC
|
MPM BioVentures 2018 GP LLC
|
N/A
|
|
-58K
|
$28.32
|
-$1.63M
|
|
SEC
|
Oncology Impact Fund (Cayman) Management L.P.
|
N/A
|
|
-96K
|
$28.32
|
-$2.73M
|
|
SEC
|
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
|
N/A
|
|
-74K
|
$16.72
|
-$1.24M
|
|
SEC
|
MPM BioVentures 2018 GP LLC
|
N/A
|
|
-74K
|
$16.72
|
-$1.24M
|
|
SEC
|
Oncology Impact Fund (Cayman) Management L.P.
|
N/A
|
|
-103K
|
$20.16
|
-$2.07M
|
|
SEC
|
Detheux Michel
|
Chief Executive Officer
|
|
-20K
|
$28.66
|
-$580.42K
|
|
SEC
|
Detheux Michel
|
Chief Executive Officer
|
|
-15K
|
$28.13
|
-$412.47K
|
|
SEC
|
Detheux Michel
|
Chief Executive Officer
|
|
-8.6K
|
$28.06
|
-$240.90K
|
|
SEC
|
Call Matthew
|
Chief Operating Officer
|
|
+54K
|
$2.95
|
+$158.33K
|
|
SEC
|
Gall Matthew
|
Chief Financial Officer
|
|
+5K
|
$26.09
|
+$130.45K
|
|
SEC
|
Detheux Michel
|
Chief Executive Officer
|
|
-29K
|
$28.50
|
-$826.50K
|
|
SEC
|
McGrath Yvonne
|
VP, Research and Development
|
|
-7.9K
|
$21.92
|
-$173.76K
|
|
SEC
|
McGrath Yvonne
|
VP, Research and Development
|
|
-7.9K
|
$24.69
|
-$195.69K
|
|
SEC
|
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
|
N/A
|
|
-119
|
$29.99
|
-$3.57K
|
|
SEC
|
MPM BioVentures 2018 GP LLC
|
N/A
|
|
-119
|
$29.99
|
-$3.57K
|
|
SEC
|
MPM Oncology Impact Management GP LLC
|
N/A
|
|
-200
|
$29.99
|
-$6.00K
|
|
SEC
|
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
|
N/A
|
|
-41K
|
$19.07
|
-$777.24K
|
|
SEC
|
MPM BioVentures 2018 GP LLC
|
N/A
|
|
-41K
|
$19.07
|
-$777.24K
|
|
SEC
|
MPM Oncology Impact Management GP LLC
|
N/A
|
|
-58K
|
$22.56
|
-$1.30M
|
|
SEC
|
Shah Rajeev M.
|
N/A
|
|
+421K
|
$34.18
|
+$14.40M
|
|
SEC
|
Davis Aaron I.
|
N/A
|
|
+4.4M
|
$19.00
|
+$83.93M
|
|
SEC
|
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
|
N/A
|
|
+3.7M
|
$19.00
|
+$70.43M
|
|
SEC
|
MPM BioVentures 2018 GP LLC
|
N/A
|
|
+3.7M
|
$19.00
|
+$70.43M
|
|
SEC
|
MVA Investors, LLC
|
N/A
|
|
+4.4M
|
$19.00
|
+$83.93M
|
|
SEC
|
Oncology Impact Fund (Cayman) Management L.P.
|
N/A
|
|
+6.1M
|
$19.00
|
+$115.18M
|
|
SEC
|
Shah Rajeev M.
|
N/A
|
|
+4.4M
|
$19.00
|
+$83.93M
|
|